No abstract available
Keywords:
glycemic control; insulin sensitivity; pancreatic function; physical activity; type 2 diabetes; weight loss.
MeSH terms
-
Diabetes Mellitus, Type 2* / drug therapy
-
Diabetes Mellitus, Type 2* / physiopathology
-
Glucagon-Like Peptide 1
-
Glucagon-Like Peptides*
-
Humans
-
Hypoglycemic Agents / pharmacology
-
Hypoglycemic Agents / therapeutic use
Substances
-
semaglutide
-
Hypoglycemic Agents
-
Glucagon-Like Peptide 1
-
Glucagon-Like Peptides